COVID-19 and bone health

被引：2
作者：
Hu, C. -L. [1 ]
Zheng, M. -J. [1 ]
He, X. -X. [1 ]
Liu, D. -C. [1 ]
Jin, Z. -Q. [1 ]
Xu, W. -H. [1 ]
Lin, P. -Y. [1 ]
Cheng, J. -W. [1 ]
Wei, Q. -G. [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Trauma Orthoped & Hand Surg, Nanning, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2023年 / 27卷 / 07期
关键词：
COVID-19; Bone health; Osteopenia; SARS-CoV-2; Cytokine storm; Long COVID; ACUTE RESPIRATORY SYNDROME; VITAMIN-D; OSTEOPOROSIS; MANAGEMENT; LONG; CHALLENGES; DENSITY; CARE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A few patients who have recovered from COVID-19 develop persistent or new symptoms that last for weeks or months; this is called "long COVID" or "post-COVID-19 syndrome." Over time, awareness of the short-and long-term consequences of COVID-19 has increased. The pulmonary consequences are now fairly well established, but little is known about the extrapulmonary system of COVID-19, particularly its effects on bones. Current evidence and reports indicate a direct relationship between SARS-CoV-2 infection and bone health, with SARS-CoV-2 having a significant negative effect on bone health. In this review, we analyzed the impact of SARS-CoV-2 infection on bone health and assessed the impact of COVID-19 on the di-agnosis and treatment of osteoporosis.
引用
收藏
页码：3191 / 3200
页数：10
相关论文
共 96 条
[1]   Avascular necrosis as a part of 'long COVID-19' [J].
Agarwala, Sanjay R. ;
Vijayvargiya, Mayank ;
Pandey, Prashant .
BMJ CASE REPORTS, 2021, 14 (07)
[2]   Corticosteroids for COVID-19: worth it or not? [J].
Akter, Fariya ;
Araf, Yusha ;
Hosen, Mohammad Jakir .
MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) :567-576
[3]   Osteoclast-mediated bone loss observed in a COVID-19 mouse model [J].
Awosanya, Olatundun D. ;
Dalloul, Christopher E. ;
Blosser, Rachel J. ;
Dadwal, Ushashi C. ;
Carozza, Mariel ;
Boschen, Karen ;
Klemsz, Michael J. ;
Johnston, Nancy A. ;
Bruzzaniti, Angela ;
Robinson, Christopher M. ;
Srour, Edward F. ;
Kacena, Melissa A. .
BONE, 2022, 154
[4]   Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study [J].
Bartoletti, Michele ;
Marconi, Lorenzo ;
Scudeller, Luigia ;
Pancaldi, Livia ;
Tedeschi, Sara ;
Giannella, Maddalena ;
Rinaldi, Matteo ;
Bussini, Linda ;
Valentini, Ilaria ;
Ferravante, Anna Filomena ;
Potalivo, Antonella ;
Marchionni, Elisa ;
Fornaro, Giacomo ;
Pascale, Renato ;
Pasquini, Zeno ;
Puoti, Massimo ;
Merli, Marco ;
Barchiesi, Francesco ;
Volpato, Francesca ;
Rubin, Arianna ;
Saracino, Annalisa ;
Tonetti, Tommaso ;
Gaibani, Paolo ;
Ranieri, Vito Marco ;
Viale, Pierluigi ;
Cristini, Francesco .
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) :105-111
[5]  
Berktas BM, 2022, EUR REV MED PHARMACO, V26, P3046, DOI 10.26355/eurrev_202204_28636
[6]   The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].
Black, Dennis M. ;
Reid, Ian R. ;
Boonen, Steven ;
Bucci-Rechtweg, Christina ;
Cauley, Jane A. ;
Cosman, Felicia ;
Cummings, Steven R. ;
Hue, Trisha F. ;
Lippuner, Kurt ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Martinez, Ruvie Lou Maria ;
Tan, Monique ;
Ruzycky, Mary Ellen ;
Su, Guoqin ;
Eastell, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254
[7]   Vitamin D Endocrine System and COVID-19 [J].
Bouillon, Roger ;
Manuel Quesada-Gomez, Jose .
JBMR PLUS, 2021, 5 (12)
[8]   Glucocorticoids and COVID-19 [J].
Bruscoli, Stefano ;
Puzzovio, Pier Giorgio ;
Zaimi, Maria ;
Tiligada, Katerina ;
Levi-Schaffer, Francesca ;
Riccardi, Carlo .
PHARMACOLOGICAL RESEARCH, 2022, 185
[9]   GILZ as a Regulator of Cell Fate and Inflammation [J].
Bruscoli, Stefano ;
Riccardi, Carlo ;
Ronchetti, Simona .
CELLS, 2022, 11 (01)
[10]   Immune regulation by glucocorticoids [J].
Cain, Derek W. ;
Cidlowski, John A. .
NATURE REVIEWS IMMUNOLOGY, 2017, 17 (04) :233-247
12345678910